Overview
FDA & Trial Timeline
9 eventsUniversity College Cork — NA
Assistance Publique - Hôpitaux de Paris — NA
Konya Necmettin Erbakan Üniversitesi — NA
Uppsala University — NA
University of Arkansas — NA
ANRS, Emerging Infectious Diseases — NA
University of Colorado, Denver — PHASE3
University of Pennsylvania — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hyper-IgM syndrome type 2.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hyper-IgM syndrome type 2 at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hyper-IgM syndrome type 2.
Community
No community posts yet. Be the first to share your experience with Hyper-IgM syndrome type 2.
Start the conversation →Latest news about Hyper-IgM syndrome type 2
Disease timeline:
New recruiting trial: Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault
A new clinical trial is recruiting patients for Hyper-IgM syndrome type 2
New recruiting trial: Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults
A new clinical trial is recruiting patients for Hyper-IgM syndrome type 2
New recruiting trial: V+PSF-M for Tobacco Cessation in HIV Care in India
A new clinical trial is recruiting patients for Hyper-IgM syndrome type 2
New recruiting trial: Enhanced Nutritional Optimization in LVAD Trial
A new clinical trial is recruiting patients for Hyper-IgM syndrome type 2
New trial: A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families
Phase NA trial recruiting. Fortified Bread
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hyper-IgM syndrome type 2
Which specialists treat Hyper-IgM syndrome type 2?
3 specialists and care centers treating Hyper-IgM syndrome type 2 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.